Observational study of HER2 positive rate in advanced or recurrent gastric cancer
Not Applicable
- Conditions
- Advanced or recurrent gastric cancer
- Registration Number
- JPRN-UMIN000006190
- Lead Sponsor
- Japanese Foundation for Multidisciplinary Treatment of Cancer
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 1200
Inclusion Criteria
Not provided
Exclusion Criteria
All patients who does not meet the key inclusion criteria
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) HER2-positive rate. 2) Relation among HER2-positive, HER2- negative, patient background factors, and specimen background factors. 3) Relation among HER2 Status, patient background factors, and specimen background factors. 4) Relation among overall survival, patient background factors, and treatment background factors.
- Secondary Outcome Measures
Name Time Method